Nanobiotix is trading 5.1% up at $40.25, based on the provided live price context; no clear company-specific catalyst has been identified.
- Searches found no clearly dated August 17, 2026 company-specific announcement, earnings release, regulatory decision, or analyst action explaining the move.
- The company’s investor-relations listings show earlier updates instead.
- Broader indexes are slightly lower, so evidence does not support attributing the gain to market-wide momentum.